4AB:FRA
AbbVie Common Stock
€254.10
arrow_downward
-0.27%(-0.70) 1D
Oct 19, 7:57:53 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€253.30
High
€256.30
Low
€253.30
Mkt. cap
500.78B
Avg. vol.
74.00
Volume
30.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57K
Open
€253.30
High
€256.30
Low
€253.30
Mkt. cap
500.78B
Avg. vol.
74.00
Volume
30.00
52-wk high
€259.60
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
ad-hoc-news.de
·
4 hours ago
AbbVie stock: At 1.84 percent below its 52-week high, AbbVie stock trades at EUR 255.05
ad-hoc-news.de
·
11 hours ago
JPMorgan raises target for AbbVie stock to USD 300
ad-hoc-news.de
·
13 hours ago
AbbVie Inc. stock at EUR 253.20 ahead of the Xetra open: pharmaceutical group little changed
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com